|
|
Crude Oil Gains 2%; Walmart Posts Upbeat Earnings
|
|
|
|
12 Health Care Stocks Moving In Thursday's Intraday Session
|
|
|
|
Dow Falls Over 250 Points; US Initial Jobless Claims Decline
|
|
|
|
Moleculin Biotech shares are trading higher after the company announced it is approaching the first unblinding of data in its pivotal Phase 2B/3 "MIRACLE" study of Annamycin in combination with cytarabine in AML treatment.
|
|
|
|
Moleculin Biotech Reports Preliminary Composite Complete Remission Rate Of 40% In Phase 2B/3 Miracle Trial's First 30 Subjects Treated, With Annamycin In Combination With Cytarabine For Refractory To Or Relapsed Acute Myeloid Leukemia After Induction Therapy
|
|